Management of Stage IIIA (N2) Non-Small Cell Lung Cancer: A Transatlantic Perspective

6Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

There is no consensus as to the optimal management of IIIA (N2) non???small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.

Cite

CITATION STYLE

APA

Rocco, G., Nason, K., Brunelli, A., Varela, G., Waddell, T., & Jones, D. R. (2016, April 1). Management of Stage IIIA (N2) Non-Small Cell Lung Cancer: A Transatlantic Perspective. Annals of Thoracic Surgery. Elsevier USA. https://doi.org/10.1016/j.athoracsur.2016.01.036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free